Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contributory role of microRNAs in anti-cancer effects of small molecule inhibitor of telomerase (BIBR1532) on acute promyelocytic leukemia cell line
Atieh Pourbagheri‐Sigaroodi, Davood Bashash, Ava Safaroghli‐Azar, et al.
European Journal of Pharmacology (2019) Vol. 846, pp. 49-62
Closed Access | Times Cited: 21

Showing 21 citing articles:

Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies
Jixuan Gao, Hilda A. Pickett
Nature reviews. Cancer (2022) Vol. 22, Iss. 9, pp. 515-532
Closed Access | Times Cited: 135
Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways
Ali Rafat, Khadijeh Dizaji Asl, Zeinab Mazloumi, et al.
Life Sciences (2022) Vol. 295, pp. 120402-120402
Closed Access | Times Cited: 42
Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA)
Jaber Haj Ali, Michael Walter
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 7
Therapeutic strategies for targeting telomerase in cancer
Xing Chen, Wenjian Tang, Jing Bo Shi, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 2, pp. 532-585
Closed Access | Times Cited: 53
The Small Molecule BIBR1532 Exerts Potential Anti-cancer Activities in Preclinical Models of Feline Oral Squamous Cell Carcinoma Through Inhibition of Telomerase Activity and Down-Regulation of TERT
Gennaro Altamura, Barbara Ďegli Uberti, Giorgio Galiero, et al.
Frontiers in Veterinary Science (2021) Vol. 7
Open Access | Times Cited: 31
Stilbene Compounds Inhibit Tumor Growth by the Induction of Cellular Senescence and the Inhibition of Telomerase Activity
Yu‐Hsuan Lee, Yu-Ying Chen, Ya-Ling Yeh, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2716-2716
Open Access | Times Cited: 34
Advances in Pediatric Acute Promyelocytic Leukemia
Shannon E. Conneely, Alexandra M. Stevens
Children (2020) Vol. 7, Iss. 2, pp. 11-11
Open Access | Times Cited: 31
CRISPR/Cas9-Mediated TERT Disruption in Cancer Cells
Luan Wen, Changzhi Zhao, Jun Song, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 653-653
Open Access | Times Cited: 29
The Relevance of Telomerase and Telomere-Associated Proteins in B-Acute Lymphoblastic Leukemia
Tales Henrique Andrade da Mota, Ricardo Camargo, Estefânia Rodrigues Biojone, et al.
Genes (2023) Vol. 14, Iss. 3, pp. 691-691
Open Access | Times Cited: 7
Evaluation of microRNA‑9 and ‑192 expression levels as biomarkers in patients suffering from breast cancer
Shaian Tavakolian, Hossein Goudarzi, Farhad Torfi, et al.
Biomedical Reports (2019)
Open Access | Times Cited: 22
Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532
Chao Liu, Hua Zhou, Xiao Bao Sheng, et al.
Bioorganic Chemistry (2020) Vol. 102, pp. 104077-104077
Closed Access | Times Cited: 16
Mechanism of Human Telomerase Reverse Transcriptase (hTERT) Regulation and Clinical Impacts in Leukemia
Mot Yee Yik, Adam Azlan, Yaashini Rajasegaran, et al.
Genes (2021) Vol. 12, Iss. 8, pp. 1188-1188
Open Access | Times Cited: 15
Circulating miR-148b-3p and miR-27a-3p can be potential biomarkers for diagnosis of pre-diabetes and type 2 diabetes: integrating experimental and in-silico approaches
Elnaz Ghoreishi, Seyedeh Zahra Shahrokhi, Faranak Kazerouni, et al.
BMC Endocrine Disorders (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Evaluating the expression level of miR-9-5p and miR-192-5p in gastrointestinal cancer: introducing novel screening biomarkers for patients
Shaian Tavakolian, Hossein Goudarzi, Ebrahim Faghihloo
BMC Research Notes (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Consecutive Inhibition of Telomerase and Alternative Lengthening Pathway Promotes Hodgkin’s Lymphoma Cell Death
Matheus Fabiao de Lima, Monique Oliveira Freitas, Mohammad K. Hamedani, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2299-2299
Open Access | Times Cited: 8
miRNAs as potential markers for breast cancer and regulators of tumorigenesis and progression (Review)
Hongxiang Mu, Wenmao Zhang, Ye Qiu, et al.
International Journal of Oncology (2021) Vol. 58, Iss. 5
Open Access | Times Cited: 6
Pharmacological preconditioning by TERT inhibitor BIBR1532 confers neuronal ischemic tolerance through TERT‐mediated transcriptional reprogramming
Xuemin Xie, Mingxi Li, Mengyao Zhou, et al.
Journal of Neurochemistry (2021) Vol. 159, Iss. 4, pp. 690-709
Open Access | Times Cited: 5
Clinical Value of Serum miRNA in Patients with Acute Promyelocytic Leukemia
Bei Zhang, Zhixin Pei, Hongxia Wang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 3
Telomerase-Responsive CRISPR System-Regulated Nanobomb for Triggering Research on Telomerase “Self-Detonation”
Wenyue Zhang, Ziyi Li, Xiaoli Lun, et al.
ACS Applied Materials & Interfaces (2024) Vol. 17, Iss. 1, pp. 725-738
Closed Access
Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519
Atieh Pourbagheri‐Sigaroodi, Ava Safaroghli‐Azar, Mehrnoosh Shanaki, et al.
Iranian journal of pharmaceutical research (2020) Vol. 19, Iss. 3, pp. 144-155
Closed Access | Times Cited: 3
Page 1

Scroll to top